Geron to Present at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Geron Corporation (NASDAQ: GERN) announced that CEO John A. Scarlett will present a company overview at the 21st Annual Needham Virtual Healthcare Conference on April 13, 2022, at 3:45 p.m. ET. The presentation can be accessed via a live webcast on Geron's Investor Relations website, with an archived replay available for 30 days afterward.

Geron is focused on the development of imetelstat, a first-in-class telomerase inhibitor, currently in two Phase 3 trials: IMerge for lower risk myelodysplastic syndromes and IMpactMF for refractory myelofibrosis.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, plans to present a company overview at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 3:45 p.m. ET.

A live webcast of the presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentation, the webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005098/en/

Aron Feingold

Investor and Media Relations

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

What is Geron Corporation's stock symbol?

Geron Corporation's stock symbol is GERN.

When will Geron Corporation present at the Needham Virtual Healthcare Conference?

Geron Corporation will present on April 13, 2022, at 3:45 p.m. ET.

How can I access the live webcast of Geron's presentation?

The live webcast can be accessed through Geron's Investor Relations website.

What is imetelstat and what trials is Geron conducting?

Imetelstat is a first-in-class telomerase inhibitor, and Geron is conducting Phase 3 trials named IMerge and IMpactMF.

How long will the webcast of Geron's presentation be available for replay?

The webcast will be available for replay for 30 days after the presentation.